Realm Therapeutics plc (RLM)

4.15 +0.89 (+27.301%)

IEX Real-Time Price

March 19, 2019 EST.

NASDAQ Capital Market : Healthcare

Prev Close 3.26

Price Open 3.36

Volume: 160,284

Avg Volume: 37,959

Market Cap: 19.35M

P/E Ratio -

52 Wk Range 1.35-13





News

Healthcare dominate midday movers (2019-03-19 12:43 SeekingAlpha)

Gainers: Vaxart (NASDAQ: VXRT ) +108% . Sorrento Therapeutics (NASDAQ: SRNE ) +34% . Conformis (NASDAQ: CFMS ) +23% . Blucora (NASDAQ: BCOR ) +20% . StoneCo (NASDAQ: STNE ) +19% . Realm Therapeutics ( RLM ) +19% . Iterum Therapeutics (NASDAQ: ITRM ) +18% . Altimmune (NASDAQ: A…

 


Statistics

Shares Outstanding: 4.66M

Top 15 Institution Percent: 30.00

Price To Sales: N/A

Price To Book: 0.63

Revenue: N/A

Gross Profit: N/A

Cash: N/A

Debt: N/A

Return On Assets: -79.05

Return On Equity: -86.72

Profit Margin: N/A

Price History

Beta: 4.02

50-day Moving Avg: 2.63

200-day Moving Avg: N/A

YTD Change: 109.99

5-day Change: 39.26

1-month Change: 63.38

3-month Change: 99.82

6-month Change: -35.16

1-year Change: -38.43

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Realm Therapeutics plc

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.realmtx.com

Realm Therapeutics PLC is a biopharmaceutical company which focuses on leveraging its proprietary immunomodulatory technology to protect and improve the health of adults and children.